Furthermore, it has been demonstrated that EZH2 is involved in innate and adaptative immune response in cancer, promoting tumor development through a cell-extrinsic mechanism that involves the inhibition of the antitumor activity of NK cells [21,22]. This evidence concerns the gene EZH2 and cancer.